Expand RNXT Menu
RNXT MENU

RNXT Latest Press Releases

-- February 5, 2026 --

RenovoRx Appoints Experienced Public Company Executive Mark Voll as Chief Financial Officer Globe Newswire 8:30 AM

-- February 4, 2026 --

RenovoRx Announces Clinical Data Supporting the TAMP Therapy Platform will be Presented at the SIO 2026 Annual Scientific Meeting Globe Newswire 8:30 AM

-- January 28, 2026 --

RenovoRx Announces Acceptance of Clinical Data Abstract at 2026 Society of Interventional Oncology Annual Scientific Meeting Globe Newswire 8:30 AM

-- January 20, 2026 --

RenovoRx Expands RenovoCath Commercial Adoption to Nine Active Cancer Centers Including City of Hope Cancer Center and Moffitt Cancer Center Globe Newswire 8:30 AM

-- January 14, 2026 --

RenovoRx to Participate in AlphaNorth Capital Event, January 16-18, 2026 Globe Newswire 8:30 AM

-- January 8, 2026 --

The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech Globe Newswire 12:08 PM
RenovoRx To Announce Promising New Clinical Data Using its TAMP Therapy Platform in an Abstract to be Presented at ASCO GI 2026 Globe Newswire 8:30 AM

-- December 11, 2025 --

RenovoRx Announces Acceptance of Clinical Data Abstract at the ASCO Gastrointestinal Cancers Symposium 2026 Globe Newswire 8:30 AM

-- December 1, 2025 --

RenovoRx CEO Shaun Bagai to Present at iAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 on December 9th Globe Newswire 8:30 AM

-- November 19, 2025 --

RenovoRx CEO Shaun Bagai to Present at the Alliance Global Partners Emerging AgBiotech/Bio-Solutions Virtual Showcase on November 20th Globe Newswire 8:30 AM

-- November 13, 2025 --

RenovoRx Reports Third Quarter 2025 Financial Results, Including Approximately $900,000 in Year-to-Date Revenue, and Provides Business Update Globe Newswire 4:05 PM

-- November 6, 2025 --

RenovoRx Strengthens Scientific Advisory Board (SAB) with Pancreatic Cancer Expert Timothy Donahue, MD Globe Newswire 8:30 AM

-- November 4, 2025 --

RenovoRx CEO Shaun Bagai to Participate at the Canaccord Genuity MedTech, Diagnostics & Digital Health & Services Forum on November 20th Globe Newswire 8:30 AM

-- October 27, 2025 --

RenovoRx to Host Third Quarter 2025 Financial Results and Business Highlights Conference Call on November 13th at 4:30 p.m. ET Globe Newswire 8:30 AM

-- October 9, 2025 --

RenovoRx Expands Scientific Advisory Board with Internationally Renowned Interventional Oncologist, Thierry de Bare, MD, PhD Globe Newswire 8:30 AM

-- September 25, 2025 --

RenovoRx's PanTheR Post-Marketing Registry Study Progresses with First Clinical Procedure and Addition of Two Participating Clinical Sites Globe Newswire 8:30 AM

-- September 11, 2025 --

RenovoRx CEO Shaun Bagai to Present at iAccess Alpha Virtual Best Ideas Fall Investment Conference 2025 on September 16th Globe Newswire 8:30 AM
Market Data Delayed 15 Minutes